- Report
- October 2024
- 196 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- July 2024
- 170 Pages
Global
From €2376EUR$2,490USD£1,991GBP
- Report
- August 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- February 2025
- 363 Pages
Global
From €5201EUR$5,450USD£4,358GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- November 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- October 2024
- 210 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- January 2025
- 180 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- June 2024
- 180 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2024
- 164 Pages
Global
From €4767EUR$4,995USD£3,994GBP
- Report
- February 2021
- 420 Pages
United States
From €2291EUR$2,400USD£1,919GBP
- Report
- August 2022
- 30 Pages
Global
From €3102EUR$3,250USD£2,599GBP
- Report
- January 2022
- 205 Pages
Global
From €7158EUR$7,500USD£5,997GBP
- Report
- April 2023
- 116 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2022
- 122 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- August 2022
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- August 2022
- 170 Pages
Global
From €3436EUR$3,600USD£2,879GBP
- Report
- July 2022
- 109 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- March 2025
- 50 Pages
Global
From €2529EUR$2,650USD£2,119GBP

Modafinil is a central nervous system (CNS) drug used to treat excessive sleepiness caused by narcolepsy, shift work sleep disorder, and obstructive sleep apnea. It is also used off-label to treat attention deficit hyperactivity disorder (ADHD), depression, and cognitive enhancement. Modafinil is a stimulant drug that works by increasing the release of dopamine in the brain, which helps to improve alertness, focus, and concentration. It is considered to be a safe and effective treatment for excessive sleepiness, with few side effects.
The modafinil market is growing rapidly, driven by the increasing prevalence of sleep disorders and the growing demand for cognitive enhancement drugs. The market is expected to be further driven by the increasing awareness of the benefits of modafinil and the increasing availability of generic versions of the drug.
Some companies in the modafinil market include Cephalon, Sun Pharmaceuticals, Teva Pharmaceuticals, Mylan, and Intas Pharmaceuticals. Show Less Read more